Status:
COMPLETED
Mobile Technology for Reducing and Preventing Adolescent Suicide
Lead Sponsor:
Hartford Hospital
Collaborating Sponsors:
Oui Therapeutics, Inc.
National Institute of Mental Health (NIMH)
Conditions:
Suicide, Attempted
Suicidal Ideation
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
This single-group open-label trial will evaluate the feasibility and preliminary efficacy of a suicide prevention mobile application when used as an adjunct to usual care in adolescents.
Detailed Description
This study will enroll 20 adolescent (age 13-17) inpatients at elevated risk for suicide. Participants will download the app onto their phones during their inpatient stay and will complete a single th...
Eligibility Criteria
Inclusion
- Inpatient psychiatric patients who have attempted suicide (lifetime) or have documented suicide ideation and a plan to harm themselves at admission
- Understand written and spoken English
- Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
- Willing and able to complete enrollment procedures
- Parent/guardian (and youth) able to understand the nature of the study and provide written informed consent (assent for youth)
- Willing to agree to release of information to their parent/guardian and providers when clinically indicated.
- Discharge plan includes aftercare within the Hartford HealthCare system (to facilitate coordination of care during follow up)
Exclusion
- Patients with active psychosis
- Patients experiencing substance withdrawal
- Currently enrolled in other treatment studies for the symptoms and behaviors targeted
- Patient unwilling or unable to wear mask during in-person study procedures
- Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the Smartphone App.
- Any other psychiatric or medical condition (e.g., intellectual disability) or custody arrangement that in the investigator's opinion would preclude informed consent/assent or participation in the trial.
Key Trial Info
Start Date :
July 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04896593
Start Date
July 12 2021
End Date
May 25 2022
Last Update
March 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Living/Hartford Hospital
Hartford, Connecticut, United States, 06106